DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Decadron (Dexamethasone) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Decadron (Dexamethasone) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (368)
Death (44)
Life Threatening Events (34)
Disability (20)

Reports by Reaction Type

Vomiting (29)Diarrhoea (27)Pneumonia (25)Nausea (25)Hypotension (24)Pyrexia (23)Renal Failure Acute (21)Fatigue (19)Asthenia (19)Platelet Count Decreased (18)Chest Pain (17)Oedema Peripheral (17)

Below are a few examples of reports where side effects / adverse reactions may be related to Decadron (Dexamethasone). For a complete list or a specific selection of reports, please use the links above.

Possible Decadron side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: male, weighing 93.4 kg (205.5 pounds)

Reactions: Confusional State, Fatigue, Pseudomembranous Colitis, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 2.95 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-02-07
    End date: 2011-03-03

Decadron
    Dosage: unk
    Indication: Multiple Myeloma

Other drugs received by patient: Zofran; Cipro / 00042702 /; Duragesic-100; Armodafinil; Xanax; Morphine Sulfate; Miralax; Valtrex



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Diabetes Mellitus, Delirium

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 18 mg, once
    Administration route: Oral
    Indication: Premedication
    Start date: 2011-06-30
    End date: 2011-06-30

Dalotuzumab
    Dosage: day 1 and day 8
    Start date: 2011-06-22
    End date: 2011-06-22

Dalotuzumab
    Dosage: day 1 and day 8
    Indication: Breast Cancer
    Start date: 2011-06-15
    End date: 2011-06-15

Decadron
    Dosage: 18 mg, qd
    Administration route: Oral
    Indication: Premedication
    Start date: 2011-07-01
    End date: 2011-07-03

Other drugs received by patient: Lidocaine; Zofran; Loratadine; Fentanyl; Cyclophosphamide; Epirubicin Hydrochloride; Pravastatin Sodium; Tylenol; Hydrochlorothiazide; Versed; Fluorouracil; Ancef



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Diabetes Mellitus

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 18 mg, once
    Administration route: Oral
    Indication: Premedication
    Start date: 2011-06-30
    End date: 2011-06-30

Decadron
    Dosage: 18 mg, qd
    Administration route: Oral
    Start date: 2011-07-01
    End date: 2011-07-03

Other drugs received by patient: Tylenol; Zofran; MK-0646; Hydrochlorothiazide; Pravastatin Sodium; Loratadine; Ancef; Lidocaine; Versed; MK-0646; Fentanyl



Possible Decadron side effects in male

Reported by a physician from United States on 2012-08-17

Patient: male, weighing 88.4 kg (194.6 pounds)

Reactions: Back Pain, Renal Failure, Pain in Extremity, Anaemia, Joint Effusion, Deep Vein Thrombosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-07-25

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Adriamycin PFS
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Decadron
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Velcade
    Dosage: 2.6 mg, cyclic
    Start date: 2011-07-25
    End date: 2012-04-23

Aredia
    Dosage: unk
    Indication: Hypercalcaemia
    Start date: 2011-03-07
    End date: 2011-07-14

Other drugs received by patient: B12-Vitamin



Possible Decadron side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Decadron side effects in 34 year old male

Reported by a consumer/non-health professional from United States on 2012-08-15

Patient: 34 year old male, weighing 99.8 kg (219.5 pounds)

Reactions: Hiccups

Drug(s) suspected as cause:
Decadron
    Dosage: 2/daily po
    Administration route: Oral
    Indication: Brain Oedema
    Start date: 2011-09-27
    End date: 2011-10-04

Decadron
    Dosage: 2/daily po
    Administration route: Oral
    Indication: Brain Oedema
    Start date: 2011-10-05
    End date: 2011-10-09



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Decadron side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Decadron side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Decadron side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Decadron side effects in

Reported by a physician from United Kingdom on 2012-08-10

Patient:

Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 64 mg, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: 2.4 mg/m2, on day 1, 4, 8, 11
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin Hydrochloride
    Dosage: 64 mg, qm
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, on day 1, 4, 8, 11
    Start date: 2010-10-18
    End date: 2010-11-09

Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Other drugs received by patient: Gabapentin; Amoxicillin; Furosemide; Acetaminophen; Furosemide; Enoxaparin Sodium



Possible Decadron side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-08

Patient: male

Reactions: Oesophageal Candidiasis, Cytomegalovirus Infection, Abdominal Pain Upper

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mabcampath
    Start date: 2012-01-09
    End date: 2012-01-11

Decadron
    Indication: Prophylaxis
    Start date: 2012-01-17
    End date: 2012-01-17

Fludarabine Phosphate
    Start date: 2012-01-09
    End date: 2012-01-11

Dexamethasone Sodium Phosphate
    Indication: Prophylaxis
    Start date: 2012-01-18
    End date: 2012-01-20

Cyclophosphamide
    Start date: 2012-01-09
    End date: 2012-01-11

Other drugs received by patient: Acyclovir; Acyclovir; Flecainide Acetate; Folina / 00024201 /; Omeprazole; Levofloxacin; Granulokine



Possible Decadron side effects in female

Reported by a physician from Japan on 2012-08-06

Patient: female

Reactions: Pneumonia, Gastrointestinal Haemorrhage, Nausea, Skin Disorder, Pleural Effusion, Liver Disorder

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Decadron
    Dosage: 4 mg, uid/qd
    Administration route: Oral
    Indication: Adenocarcinoma Pancreas
    Start date: 2012-05-31
    End date: 2012-06-02

Decadron
    Dosage: 8 mg, uid/qd
    Administration route: Oral
    Start date: 2012-06-20

Erlotinib Hydrochloride
    Dosage: 100 mg, uid/qd
    Administration route: Oral
    Indication: Adenocarcinoma Pancreas
    Start date: 2012-05-23
    End date: 2012-06-03

Tramadol Hydrochloride
    Dosage: 125 mg, uid/qd
    Administration route: Oral
    Start date: 2012-06-23
    End date: 2012-06-25

Decadron
    Dosage: 8 mg, uid/qd
    Administration route: Oral
    Start date: 2012-06-04
    End date: 2012-06-08

Loxonin
    Dosage: 180 mg, uid/qd
    Administration route: Oral
    Indication: Adenocarcinoma Pancreas
    End date: 2012-06-06

Tramadol Hydrochloride
    Dosage: 75 mg, uid/qd
    Administration route: Oral
    Indication: Adenocarcinoma Pancreas
    Start date: 2012-05-23
    End date: 2012-06-08

Other drugs received by patient: Gemcitabine Hydrochloride; Urso / 00465701 /; Pancrelipase; Magnesium Oxide; Baraclude; Protecadin



Possible Decadron side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-03

Patient: 71 year old female

Reactions: Nausea, Palpitations, Cold Sweat, Shock

Drug(s) suspected as cause:
Decadron
    Dosage: 0.3 mg;biw;iv,0.3 mg;biw;iv,0.3 mg;biw;iv
    Start date: 2012-07-19
    End date: 2012-07-19

Decadron
    Dosage: 0.3 mg;biw;iv,0.3 mg;biw;iv,0.3 mg;biw;iv
    Start date: 2012-06-07
    End date: 2012-06-07

Decadron
    Dosage: 0.3 mg;biw;iv,0.3 mg;biw;iv,0.3 mg;biw;iv
    Start date: 2012-06-21
    End date: 2012-06-21

Zantac
    Dosage: ,50 mg;biw;iv,50 mg;biw;iv
    Start date: 2012-07-19
    End date: 2012-07-19

Zantac
    Dosage: ,50 mg;biw;iv,50 mg;biw;iv
    Start date: 2012-06-07
    End date: 2012-06-07

Zantac
    Dosage: ,50 mg;biw;iv,50 mg;biw;iv
    Start date: 2012-06-21
    End date: 2012-06-21

Other drugs received by patient: Celestamine TAB; Paclitaxel; Ramosetron; Carboplatin; Hydrochloride



Possible Decadron side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-01

Patient:

Reactions: Diarrhoea, Drug Ineffective, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 64 mg, qm
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin Hydrochloride
    Dosage: 64 mg, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: 2.4 mg/m2, qd
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: 2.4 mg/m2, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Other drugs received by patient: Enoxaparin Sodium; Gabapentin; Acetaminophen; Amoxicillin; Furosemide; Furosemide



Possible Decadron side effects in female

Reported by a physician from Japan on 2012-07-31

Patient: female, weighing 34.5 kg (75.9 pounds)

Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Febrile Neutropenia, Multiple Myeloma, Neutrophil Count Decreased, Hypertension

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-02
    End date: 2010-10-22

Decadron
    Dosage: 6.6mg x 2
    Start date: 2010-10-30
    End date: 2010-11-02

Decadron
    Dosage: 1.65g x 1
    Start date: 2010-10-30
    End date: 2010-11-02

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-11-27
    End date: 2010-12-02

Decadron
    Dosage: 6.6mg x 5
    Start date: 2010-10-10
    End date: 2010-10-13

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2010-10-30
    End date: 2010-11-19

Decadron
    Dosage: 6.6mg x 5
    Indication: Multiple Myeloma
    Start date: 2010-10-02
    End date: 2010-10-05

Other drugs received by patient: Omeprazole; Lasix; Fentanyl-100; Lasix; Orgaran; Loxonin; Neophyllin



Possible Decadron side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-30

Patient: 71 year old female

Reactions: Palpitations, Nausea, Cold Sweat, Shock

Drug(s) suspected as cause:
Zantac
    Dosage: 50mg two times per week
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-07
    End date: 2012-06-07

Zantac
    Dosage: 50mg two times per week

Zantac
    Dosage: 50mg two times per week
    Start date: 2012-06-21
    End date: 2012-06-21

Decadron
    Dosage: .3mg two times per week
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-07
    End date: 2012-06-07

Zantac
    Dosage: 50mg two times per week
    Start date: 2012-07-19
    End date: 2012-07-19

Decadron
    Dosage: .3mg two times per week
    Start date: 2012-07-19
    End date: 2012-07-19

Decadron
    Dosage: .3mg two times per week
    Start date: 2012-06-21
    End date: 2012-06-21

Decadron
    Dosage: .3mg two times per week

Other drugs received by patient: Carboplatin; Celestamine TAB; Paclitaxel; Ramosetron Hydrochloride



Possible Decadron side effects in 1 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-25

Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Pneumonia Fungal, Electrocardiogram QT Prolonged, Renal Disorder, Malnutrition, Disseminated Intravascular Coagulation, Clostridium Colitis, Gastric Ulcer, Pneumonia Cytomegaloviral, Liver Disorder, Hypokalaemia, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Romiplostim
    Dosage: 1 mg/kg, qwk
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-06-01
    End date: 2011-06-08

Romiplostim
    Dosage: 2 mg/kg, qwk
    Start date: 2011-06-15
    End date: 2011-06-15

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2011-06-24
    End date: 2012-06-24

Funguard
    Dosage: uncertainty

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-08-09
    End date: 2011-08-09

Decadron
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-05-20
    End date: 2011-06-17

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-07-21
    End date: 2011-08-06

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-10-17

Romiplostim
    Dosage: 9 mg/kg, qwk
    Start date: 2011-09-08
    End date: 2011-09-08

Bactrim
    Dosage: unk

Zosyn
    Dosage: unk

Ambisome
    Dosage: uncertainty

Romiplostim
    Dosage: 4 mg/kg, qwk
    Start date: 2011-07-11
    End date: 2011-07-11

Romiplostim
    Dosage: 8 mg/kg, qwk
    Start date: 2011-09-01
    End date: 2011-09-01

Cyclosporine
    Dosage: uncertainty

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2012-06-21
    End date: 2012-06-21

Cellcept
    Dosage: uncertainty
    Administration route: Oral

Romiplostim
    Dosage: 6 mg/kg, qwk
    Start date: 2011-08-16
    End date: 2011-08-16

Romiplostim
    Dosage: 7 mg/kg, qwk
    Start date: 2011-08-24
    End date: 2011-08-24

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-09-15
    End date: 2011-10-13

Rituxan

Meropenem
    Dosage: unk
    Indication: Prophylaxis

Other drugs received by patient: Prednisolone; Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Famotidine; Danazol; Danazol; Immune Globulin (Human); Cefazolin Sodium; Prednisolone; Prednisolone; Prednisolone; Prednisolone



Possible Decadron side effects in male

Reported by a physician from United States on 2012-07-23

Patient: male

Reactions: Rash, Diverticular Perforation

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-10-01

Decadron
    Dosage: 5.7143 milligram
    Indication: Multiple Myeloma
    Start date: 2011-07-02

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-05-01
    End date: 2011-08-16

Other drugs received by patient: Iron; Lovaza; Bactrim; Valtrex; Synthroid; Proventil; Ambien; Vitamin D; Glucosamine; Halog; Steroids; Aciphex; B-50 Complex; Proventil Gentlehaler; Symbicort; Zyrtec; Aspirin; Multi-Vitamins



Possible Decadron side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-23

Patient: male

Reactions: Oesophageal Candidiasis, Cytomegalovirus Infection, Abdominal Pain Upper

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Indication: Prophylaxis
    Start date: 2012-01-17
    End date: 2012-01-17

Cyclophosphamide
    Start date: 2012-01-09
    End date: 2012-01-11

Fludarabine Phosphate
    Start date: 2012-01-09
    End date: 2012-01-11

Mabcampath
    Start date: 2012-01-09
    End date: 2012-01-11

Dexamethasone Sodium Phosphate
    Indication: Prophylaxis
    Start date: 2012-01-18
    End date: 2012-01-20

Other drugs received by patient: Granulokine; Flecainide Acetate; Folina / 00024201 /; Omeprazole; Acyclovir; Levofloxacin



Possible Decadron side effects in 70 year old male

Reported by a consumer/non-health professional from Italy on 2012-07-23

Patient: 70 year old male

Reactions: Drug Level Increased, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alfuzosin HCL

Phenytoin Sodium
    Dosage: 1 df = 4 doses/day strength:250mg/5ml
    Indication: Convulsion
    Start date: 2012-05-16
    End date: 2012-05-29

Acyclovir
    Administration route: Oral
    Indication: Convulsion
    Start date: 2012-05-16
    End date: 2012-06-06

Prostigmina
    Dosage: 1df=0.5mg/ml.

Lantus

Omeprazole
    Administration route: Oral

Merrem
    Indication: Encephalitis
    Start date: 2012-05-29
    End date: 2012-05-31

Enoxaparin Sodium
    Dosage: 1 dose

Lasix
    Dosage: 3 doses

Omnipaque 140
    Indication: Computerised Tomogram
    Start date: 2012-05-29

Acetylsalicylic Acid SRT
    Administration route: Oral

Keppra
    Dosage: 2 doses
    Administration route: Oral
    Indication: Convulsion
    Start date: 2012-05-19
    End date: 2012-06-06

Ampicillin
    Indication: Encephalitis
    Start date: 2012-05-19
    End date: 2012-05-29

Glicorest
    Dosage: 3 doses
    Administration route: Oral

Calcium Gluconate

Decadron



Possible Decadron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-20

Patient:

Reactions: Nervous System Disorder

Drug(s) suspected as cause:
Hydrocortone
    Dosage: followed by tapering daily doses
    Administration route: Oral
    Indication: Hypotension

Decadron
    Dosage: followed by tapering daily doses
    Administration route: Oral
    Indication: Hypotension



Possible Decadron side effects in

Reported by a physician from Japan on 2012-07-19

Patient:

Reactions: Colon Cancer, Periodontitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-07-19
    End date: 2012-01-21

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-07-19
    End date: 2012-01-20

Velcade
    Dosage: 1.3 mg/m2, unk
    Start date: 2012-01-31
    End date: 2012-06-26

Decadron
    Dosage: 2 mg, qd
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-31
    End date: 2012-06-27

Dexamethasone
    Dosage: 8 mg, qd
    Administration route: Oral
    Start date: 2012-01-31
    End date: 2012-06-27

Other drugs received by patient: Hachiazule / 00523101 /; Catlep; Flumarin / 00963302 /; Flomax; Gaster / 00706001 /; Gaster / 00706001 /; Hachiazule / 00523101 /; Rebamipide; Hachiazule / 00523101 /; Clarithromycin



Possible Decadron side effects in

Reported by a consumer/non-health professional from United Kingdom on 2012-07-19

Patient:

Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Decadron
    Dosage: 160 mg, qm
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: 2.4 mg/m2, qd
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: 2.4 mg/m2, qd
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg, qm
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Other drugs received by patient: Amoxicillin; Furosemide; Furosemide; Enoxaparin Sodium; Acetaminophen; Gabapentin



Possible Decadron side effects in 65 year old

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: 65 year old

Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Acidosis, Prothrombin Time Prolonged, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, White Blood Cell Count Decreased, Hypotension, International Normalised Ratio Increased, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Alkeran
    Indication: Product Used FOR Unknown Indication

Decadron
    Indication: Product Used FOR Unknown Indication



Possible Decadron side effects in 1 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13

Patient: 1 year old male, weighing 18.0 kg (39.6 pounds)

Reactions: Electrocardiogram QT Prolonged, Pneumonia Fungal, Renal Disorder, Disseminated Intravascular Coagulation, Malnutrition, Gastric Ulcer, Clostridium Colitis, Pneumonia Cytomegaloviral, Hypokalaemia, Liver Disorder, Pneumocystis Jiroveci Pneumonia, Pneumonia Bacterial, Pancreatitis, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2011-06-24
    End date: 2012-06-24

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-09-15
    End date: 2011-10-13

Cyclosporine
    Dosage: uncertainty

Romiplostim
    Dosage: 2 mg/kg, qwk
    Start date: 2011-06-15
    End date: 2011-06-15

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-07-21
    End date: 2011-08-06

Romiplostim
    Dosage: 6 mg/kg, qwk
    Start date: 2011-08-16
    End date: 2011-08-16

Cellcept
    Dosage: uncertainty
    Administration route: Oral

Meropenem
    Dosage: unk
    Indication: Prophylaxis

Romiplostim
    Dosage: 5 mg/kg, qwk
    Start date: 2011-08-09
    End date: 2011-08-09

Romiplostim
    Dosage: 10 mg/kg, qwk
    Start date: 2011-10-17

Ambisome
    Dosage: uncertainty

Romiplostim
    Dosage: 8 mg/kg, qwk
    Start date: 2011-09-01
    End date: 2011-09-01

Romiplostim
    Dosage: 9 mg/kg, qwk
    Start date: 2011-09-08
    End date: 2011-09-08

Decadron
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-05-20
    End date: 2011-06-17

Rituxan

Funguard
    Dosage: uncertainty

Romiplostim
    Dosage: 4 mg/kg, qwk
    Start date: 2011-07-11
    End date: 2011-07-11

Zosyn
    Dosage: unk

Romiplostim
    Dosage: 1 mg/kg, qwk
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-06-01
    End date: 2011-06-08

Romiplostim
    Dosage: 3 mg/kg, qwk
    Start date: 2012-06-21
    End date: 2012-06-21

Romiplostim
    Dosage: 7 mg/kg, qwk
    Start date: 2011-08-24
    End date: 2011-08-24

Bactrim
    Dosage: unk

Other drugs received by patient: Danazol; Famotidine; Prednisolone; Prednisolone; Danazol; Prednisolone; Cefazolin Sodium; Prednisolone; Immune Globulin (Human); Prednisolone; Fungizone; Prednisolone; Prednisolone; Prednisolone; Prednisolone



Possible Decadron side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient: male, weighing 88.4 kg (194.6 pounds)

Reactions: Back Pain, Renal Failure, Pain in Extremity, Anaemia, Joint Effusion

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-07-25

Adriamycin PFS
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Aredia
    Dosage: unk
    Indication: Hypercalcaemia
    Start date: 2011-03-07
    End date: 2011-07-14

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Velcade
    Dosage: 2.6 mg, cyclic
    Start date: 2011-07-25
    End date: 2012-04-23

Decadron
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-03-07
    End date: 2011-07-14

Other drugs received by patient: B12-Vitamin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017